Summit Therapeutics touts a rare triumph over Keytruda in lung cancer from a China-only Phase 3 study

Hours be­fore Amer­i­ca’s biggest can­cer con­fer­ence starts in Chica­go, a small biotech may have stolen the show, tout­ing late-stage re­sults in a Thurs­day af­ter­noon press …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.